South Dakota Investment Council Catalent, Inc. Transaction History

South Dakota Investment Council

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 08, 2022	SELL	$119.57 - $139.07 $29,892 - $34,767	-250 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$109.17 - $142.35 $436,680 - $569,400	-4,000 Reduced 94.12%	250 $33,000
Q1 2021 May 13, 2021	SELL	$101.51 - $125.27 $781,627 - $964,579	-7,700 Reduced 64.44%	4,250 $448,000
Q4 2020 Feb 12, 2021	SELL	$85.88 - $105.36 $644,100 - $790,200	-7,500 Reduced 38.56%	11,950 $1.24 Million
Q1 2020 May 11, 2020	SELL	$36.95 - $62.95 $739 - $1,259	-20 Reduced 0.1%	19,450 $1.01 Million
Q4 2019 Feb 11, 2020	SELL	$47.06 - $56.64 $15,059 - $18,124	-320 Reduced 1.62%	19,470 $1.1 Million
Q3 2019 Nov 13, 2019	BUY	$47.45 - $58.05 $65,955 - $80,689	1,390 Added 7.55%	19,790 $943,000
Q3 2018 Nov 14, 2018	BUY	$40.12 - $45.55 $738,208 - $838,120	18,400 New	18,400 $838,000

515

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of South Dakota Investment Council, based on Form 13F filings with the SEC.

Stay updated on South Dakota Investment Council with notifications on news.